引用本文:汪燕.丹红注射液联合前列地尔治疗缺血性脑血管病50例[J].世界中医药,2012,7(4):. |
|
丹红注射液联合前列地尔治疗缺血性脑血管病50例 |
Treatment of Danhong injection combined with alprostadil injection for 50 Cases of ischemic cerebrovascular disease |
投稿时间:2012-05-02 |
DOI: |
中文关键词: 缺血性脑血管病 丹红注射液 前列地尔 疗效 |
English Keywords:Ischemic0 cerebrovascular disease Danhong injection alprostadil efficacy |
基金项目: |
|
摘要点击次数: 1583 |
全文下载次数: 1841 |
中文摘要: |
目的:观察丹红注射液联合前列地尔治疗缺血性脑血管病的临床疗效。方法:将100例缺血性脑血管病患者随机分为治疗组和对照组,对照组给予前列地尔治疗,治疗组在对照组基础上联用丹红注射液治疗,通过比较2组治疗前后的神经功能缺损程度评分及生活能力状态分级,予以统计分析。结果:治疗组疗效明显高于对照组,2组总有效率比较,差异有统计学意义(P<0.05),治疗组治疗后的神经功能缺损及生活能力改善评分均高于对照组(P<0.05)。结论:丹红注射液联合前列地尔对缺血性脑血管病治疗效果显著。 |
English Summary: |
To observe the clinical effects of Danhong injection combined with alprostadil injection on ischemic cerebrovascular disease.Methods:One hundred cases of ischemic cerebrovascular disease were randomly divided into treatment group and control group respectively. Alprostadil injection was used for the control group,while Danhong injection combined with alprostadil injection was used for the treatment group. The neurological deficit and improving life skills scores were compared between the two groups before and after treatment.Results:The clinical efficacy in treatment group was better than control group (P<0.05). Neurological deficit and improving life skills scores in treatment group were higher than that in the control group (P<0.05). Conclusion:It has an obvious effect treating ischemic cerebrovascular disease with Danhong injection combined with alprostadil injection. |
查看全文 查看/发表评论 下载PDF阅读器 |